Ardent Health Partners (ARDT)
NYSE: ARDT
· Real-Time Price · USD
12.47
-0.02 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
12.48
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT
Ardent Health Partners Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Mar 31, 2023 |
Cash & Equivalents | 540.63M | 495.04M | 556.78M | 563.14M | 334.54M | 372.77M | 437.58M | -477.52M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 955.05M |
Long-Term Investments | n/a | 1.36M | 11.46M | 3.31M | 7.88M | 18.67M | n/a | n/a |
Other Long-Term Assets | 111.19M | 115.55M | 131.5M | 134M | 136.62M | 125.94M | 147.11M | -477.52M |
Receivables | 821.64M | 776.52M | 743.03M | 705.75M | 720.99M | 722.68M | 775.45M | n/a |
Inventory | 118.4M | 120.36M | 115.09M | 108.23M | 105.01M | 106M | 105.48M | n/a |
Other Current Assets | 268.56M | 238.97M | 304.09M | 313.57M | 205.22M | 191.38M | 222.29M | n/a |
Total Current Assets | 1.88B | 1.76B | 1.83B | 1.69B | 1.5B | 1.49B | 1.62B | 477.52M |
Property-Plant & Equipment | 2.07B | 2.06B | 2.04B | 2.01B | 2B | 2B | 2.01B | n/a |
Goodwill & Intangibles | 954.61M | 953.52M | 929.01M | 928.93M | 928.93M | 929.05M | 921.63M | n/a |
Total Long-Term Assets | 3.15B | 3.15B | 3.12B | 3.11B | 3.11B | 3.1B | 3.11B | -477.52M |
Total Assets | 5.03B | 4.91B | 4.96B | 4.8B | 4.61B | 4.59B | 4.73B | n/a |
Account Payables | 364.45M | 371.92M | 401.25M | 368.85M | 371.1M | 383.09M | 474.54M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 19.33M | 17.76M | 9.23M | 12.17M | 10.72M | 16.64M | 18.61M | n/a |
Other Current Liabilities | 237.93M | n/a | 44.66M | n/a | 278.38M | 216.43M | 66.37M | n/a |
Total Current Liabilities | 880.87M | 830.14M | 945.42M | 887.33M | 908.56M | 834.77M | 994.1M | n/a |
Long-Term Debt | 1.09B | 1.09B | 1.07B | 1.16B | 1.08B | 1.08B | 1.17B | n/a |
Other Long-Term Liabilities | 252.66M | 258.14M | 261.75M | 285.64M | 299.55M | 404.54M | 319.55M | n/a |
Total Long-Term Liabilities | 2.5B | 2.52B | 2.49B | 2.53B | 2.54B | 2.64B | 2.66B | n/a |
Total Liabilities | 3.38B | 3.35B | 3.43B | 3.41B | 3.45B | 3.48B | 3.65B | n/a |
Total Debt | 2.27B | 2.28B | 2.28B | 1.17B | 2.25B | 2.34B | 2.4B | n/a |
Common Stock | 1.43M | 1.43M | 1.43M | 1.43M | 497.62M | 497.39M | n/a | n/a |
Retained Earnings | 480.13M | 407.18M | 365.8M | 251.59M | 225.27M | 182.5M | 155.45M | n/a |
Comprehensive Income | -396K | 3.93M | 9.74M | 9.49M | 17.01M | 19.26M | 18.56M | 639.05M |
Shareholders Equity | 1.25B | 1.18B | 1.13B | 1.01B | 739.9M | 699.16M | n/a | 1.05B |
Total Investments | n/a | 1.36M | 11.46M | 3.31M | 7.88M | 18.67M | n/a | 955.05M |